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ABSTRACT: Structural characterization of membrane
proteins and other large proteins with NMR relies
increasingly on perdeuteration combined with incorpo-
ration of speciﬁcally protonated amino acid moieties, such
as methyl groups of isoleucines, valines, or leucines. The
resulting proton dilution reduces dipolar broadening
producing sharper resonance lines, ameliorates spectral
crowding, and enables measuring of crucial distances
between and to methyl groups. While incorporation of
speciﬁc methyl labeling is now well established for
bacterial expression using suitable precursors, correspond-
ing methods are still lacking for cell-free expression, which
is often the only choice for producing labeled eukaryotic
membrane proteins in mg quantities. Here we show that
we can express methyl-labeled human integral membrane
proteins cost-eﬀectively by cell-free expression based of
crude hydrolyzed ILV-labeled OmpX inclusion bodies.
These are obtained in Escherichia coli with very high
quantity and represent an optimal intermediate to channel
ILV precursors into the eukaryotic proteins.
Many biologically important proteins that are diﬃcult tocrystallize but small enough for NMR studies cannot be
produced in bacterial systems at suﬃciently high levels needed
for isotope labeling because they are toxic to the expression
host or vulnerable to the bacterial environment. This includes
not only human integral membrane proteins but also other
factors interfering with bacterial biology. This problem can
often be overcome with cell-free expression methods.1−3 Other
important advantages are associated with combinatorial label-
ing,4−6 since amino-acid scrambling is not a problem, with
unnatural amino acids, post-translationally modiﬁed residues,
ﬂuorescent probes, or metal-binding tags.7,8 Particularly studies
of membrane proteins beneﬁt from cell-free expression systems,
which tend to provide high yields required for NMR and can
provide folded protein in the presence of detergents, polymers,9
or nanodiscs.10
Unfortunately, cell-free expression cannot achieve isotope
labeling with precursors, such as 13C glucose or more
speciﬁcally labeled metabolites, since it lacks the full bacterial
metabolism for precursor incorporation into proteins. Instead,
adding labeled amino acids is needed. Aside from Stereo-Array
Isotope Labeling (SAIL),11 associated with high costs, selective
methyl-labeling methods12−14 have thus not been available for
cell-free systems so far. In particular for 13C1H methyl-labeled
Ile, Leu, and Val (ILV) in a deuterated background, used
extensively for structure determination and dynamics studies of
large proteins, no amino acids that would be suitable are
commercially available to-date.
Speciﬁc methyl labeling largely facilitates structure elucida-
tion for several reasons: Methyls report on hydrophobic
contacts crucial for the deﬁnition of interfaces between
secondary structure elements in the core.16 They also serve
as important reporters in membrane proteins, which are
particularly rich in hydrophobic amino acids. NMR studies of
large protein complexes as well as detergent- or nanodisc-
solubilized membrane proteins require high deuteration levels
and beneﬁt from the removal of 13C−13C couplings. Therefore,
the use of fully protonated 15N/13C amino acids is not suitable.
In contrast, isolated protonated methyls in deuterated back-
ground17 and stereoselective methyl labeling18 allow detection
of long NOE distance restraints, oﬀer slow transverse relaxation
rates, and exhibit wide signal dispersion.19 Isolated methyls are
also excellent reporters for internal protein motion14 and
measuring intermolecular NOEs.20 ILV labeling schemes, well
established for bacterial expression using appropriate precur-
sors, are thus highly desirable for cell-free methods. Here, we
report on an easy, aﬀordable, and practical procedure for
incorporating methyl-labeled ILV amino acids into cell-free-
expressed membrane proteins. In general, this procedure is
widely applicable to any other residue-speciﬁc labeling scheme
compatible with heterologous bacterial expression. We
demonstrate the potential of this method using the membrane
anchor of the transcriptional-activator precursor sterol regu-
latory element binding protein (SREBP), which regulates
cellular cholesterol and fatty acid synthesis.21 So far bacterial
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overexpression of the anchor was impracticable presumably due
to toxicity to Escherichia coli or rapid degradation.
ILV labeling in a cell-free expression setup can be achieved
using a multistep procedure (see Figure 1). First, commercial
ILV precursors are eﬃciently incorporated into suitable protein
biomass. This is achieved by overexpression of the outer
membrane protein X (OmpX) in E. coli. Here OmpX is
overexpressed at very high yield but targeted to inclusion
bodies, which makes it harmless to the bacteria. This results in
high protein yields of the desired labeling pattern. By growing
fully ILV-labeled cell mass containing a high-level expressing
protein, the ILV precursors as the limiting resource are
eﬃciently channeled into desired material. In addition to high
expression yields, a suﬃcient amount of ungrouped aliphatic
amino acids seems favorable for the inclusion bodies.
Hydrolysis of grouped aliphatic amino acids (Val-Val, Ile-Ala,
Ala-Ala etc.) requires longer reaction times compared to
unproblematic amino acids, presumably due to steric factors
and polarity.22 In OmpX, out of the 28 Ala, Val, Leu, and Ile
residues (19% of all residues), only three grouped combinations
are formed. After cell harvest, the inclusion bodies are puriﬁed
by repeated extensive sonication in the presence and absence of
Triton-X100. They are then hydrolyzed by treatment with
excess methanesulfonic acid at 115 °C for 3 d in the presence of
20% imidazole as a suicide base, similar to experimental
conditions used for general amino acid extraction.23,24
Puriﬁcation of the hydrolyzed mixture is achieved by cation
exchange chromatography using a Dowex AG50W-X8 resin via
a pH gradient provided by an acqueous piperidine solution,
solvent evaporation and amino-acid redissolution, and ﬁltration
of the aqueous solution using a 500 Da membrane. From 1l
minimal medium, we obtained around 300 mg of inclusion
bodies, which translates into ∼200 mg ILV-labeled amino acids.
In the last step we employed cell-free protein expression based
on the crude ILV amino acids. Out of 9 mL reaction solution
(using 300 mg ILV-labeled amino acids) we obtained ∼31 mg
of precipitated SREBP1 membrane anchor. Cell-free expression
of SREBP was pursued according to published procedures1
using an optimized pIVEX2.4d (Roche Biosciences) construct.
Its puriﬁcation and refolding will be described elsewhere. The
obtained yield is similar as achieved with commercially
available, uniformly labeled algal mixtures. See Supporting
Information (SI) for more details.
ILV cell-free expression was pursued for two exemplary ILV-
labeling patterns, i.e., for methyl assignments (providing fully
13C-labeled side chains and backbone) and for NOESY
experiments (with 13C only present in the methyls). In the
ﬁrst case, M9 media prepared in ∼95% D2O and containing
15NH4Cl and
13C, 2H-glucose as the sole carbon source was
used for OmpX expression. α-ketoisovalerate and α-ketobuty-
rate as fully 1H/13C-labeled precursors were added before
induction. In the second case, we used 12C, 2H-glucose as the
carbon source and added α-ketobutyrate and ethyl 2-hydroxy
2-13C-methyl 3-oxobutanoate as methyl-labeling precursors.18
The latter procedure results in δ-1H/13C-methyl Ile and
stereoselective labeling of only the pro-S-methyl in Leu and
Val in otherwise u-2H/12C labeled OmpX inclusion bodies.18
Figure 2A shows the HSQC pattern of the methyl region
recorded on a fully 2H, 15N,13C-labeled, ILV-methyl protonated
SREBP1 membrane anchor. The doublet pattern in the 13C
dimension in this case corroborates successful incorporation of
this labeling pattern, which is required for commonly used
methyl assignment experiments. The strong peak at 0.9 and
16.5 ppm proton and carbon chemical shift, respectively,
originates from protonated detergent (lyso-myristoyl glycerol-
phosphoglycerol, LMPG) and can be alleviated by deuteration
(see Figure 7, SI). Figure 2B depicts a similar spectrum of the
anchor as shortened by S1P protease,15 however largely
simpliﬁed due to stereoselective methyl Val/Leu labeling,
where only one of the two methyl groups is visible. These
examples highlight the potential of the presented protocol for
membrane protein NMR structure determination. Figure 3
represents an excerpt from a time-shared 15N/13C-edited
NOESY,25 which can be used to obtain structural restraints
(measured at 800 MHz in 5 d experimental time).
Cell-free expression is emerging as an important and
increasingly popular method for membrane proteins and
other challenging targets. The unavailability of methyl labeling
for cell-free protein expression, however, has been a crucial
limitation for suitable structure-elucidation methods. The
Figure 1. Cell-free-expression procedure for the production of ILV-
labeled proteins. A set of commercial precursors is eﬃciently
channeled into ILV-labeled OmpX using E. coli expression. Cell-free
expression of the ILV-labeled protein of interest is then achieved using
the crude amino acids obtained from hydrolyzed inclusion bodies.
Figure 2. 1H−13C correlated spectra of the methyl region of the ILV-
labeled SREBP membrane anchor in LMPG micelles. (A) The full-
length anchor with fully ILV-methyl-1H/13C-labeling in otherwise
u-2H,15N,13C protein. This construct contains 1 Ile, 10 Val, and 21 Leu
residues. (B) The anchor as it remains after S1P cleavage,15
stereoselectively ILV methyl labeled in an otherwise u-2H,15N labeled
background. Additionally, u-1H,15N,13C alanines were incorporated
here. The 13C-HSQC spectra were recorded in 3 h on a Bruker 800
MHz spectrometer. Gray annotations denote amino-acid-type assign-
ments. The asterisk marks the natural abundance methyl signal of
unlabeled LMPG. Residues with visible methyls are highlighted; bold
italics are denoting residues inside the micelle.
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described routine is reasonably straightforward and comparably
inexpensive and does not require any specialized chemistry
equipment besides a rotary evaporator. The feasibility hinges
on the high-yield ILV inclusion body expression of the native E.
coli membrane protein OmpX. This approach may enable
structure elucidation of numerous membrane proteins by NMR
where commonly used protein production and labeling
methods might fail.
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Reckel, S.; Sobhanifar, S.; Dötsch, V.; Bernhard, F. Nat. Protoc. 2007,
2, 2945.
(2) Spirin, A. S., Swartz, J. R. Cell-free Protein Synthesis: Methods and
Protocols; Wiley-VCH: Weinheim, 2008.
(3) Klammt, C.; Maslennikov, I.; Bayrhuber, M.; Eichmann, C.;
Vajpai, N.; Chiu, E. J.; Blain, K. Y.; Esquivies, L.; Kwon, J. H.; Balana,
B.; Pieper, U.; Sali, A.; Slesinger, P. A.; Kwiatkowski, W.; Riek, R.;
Choe, S. Nat. Methods 2012, 9, 834.
(4) Trbovic, N.; Klammt, C.; Koglin, A.; Löhr, F.; Bernhard, F.;
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Figure 3. Methyl-amide NOESY contacts obtained for the stereo-ILV-
labeled SREBP membrane anchor truncated in the same manner as
after native S1P cleavage. (A) Val/Leu region of the ﬁrst 1H/13C 2D
plane as a reference. (B) Strips for an exemplary residue (L488) from
the 13C-edited NOESY (left, at an F2
13C shift as indicated by the
arrow in A) and the matching 15N-edited NOESY strip (right, at L488
15NH chemical shift). Methyl resonances have not been unambiguously
assigned at this point. All of these spectra were obtained
simultaneously using a time-shared 15N/13C-edited NOESY experi-
ment25 at 800 MHz.
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